US Point-Of-Care Testing Market Investigated by In-demand VPG Report Published at MarketPublishers.com02 Jun 2014 • by Natalie Aster
LONDON – The constantly intensifying economic pressures on hospitals, rapidly changing consumer demands along with on-going advances in diagnostic technologies and fiercer competition amid physicians and suppliers are altogether facilitated the transitioning of diagnostic testing from commercial laboratories and hospitals closer to the patient. A range of certain factors including, among others, the increasing prevalence of infectious diseases, rising incidence of various lifestyle diseases, the declining number of technicians in central labs and also constant technological advancements are boosting the demand for point-of-care (POC) testing. On-going evolution of POC testing procedures presents a slew of lucrative opportunities for the market players.
Tosoh, Abbott, Becton Dickinson, Matritech, Ortho-Clinical Diagnostics, Roche, Corgenix, Agilent Technologies, Eiken Chemical, Siemens, Biomerieux and Helena Laboratories are among the entrenched participants in the US POC testing market.
In-demand research report “New Frontiers in the US Point-of-Care/POC Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape” worked out by Venture Planning Group (VPG) gives an up-close look at the US POC diagnostic testing market.
The report presents an extensive summary of the domestic POC testing market. It outlines and examines the major business opportunities and challenges; includes the top companies’ profiles, delves deep into the competitive landscape, discloses authoritative data on the market size, highlights the regulative environment and examines the market dynamics. Besides, the research study provides an insightful overview of the existing and emerging tests and technologies, touches upon the prevailing market trends, offers a thorough discussion of the most important industry related issues.
Market sectors investigated: home/personal testing, operating/recovery suites, physician offices/group practices, ambulatory care centers, emergency rooms, nursing homes, ICUs/CCUs, surgery centers, cancer clinics, nursing homes and ambulatory care centers.
New Frontiers in the US Point-of-Care/POC Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape
Published: May, 2014
Price: US$ 16,500.00
Other Recent In-Vitro Diagnostics Markets Reports by VPG:
- New Frontiers in Point-of-Care/POC Diagnostic Testing: Global Challenges, Emerging Technologies, Competitive Landscape
- New Frontiers in US Critical Care (ER, OR, ICU) Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape
- New Frontiers in Physician Office Diagnostic Testing: Business Challenges, Emerging Technologies, Competitive Landscape
- New Frontiers in Ancillary Hospital Location Diagnostic Testing (ER, OR, ICU): Business Challenges, Emerging Technologies, Competitive Landscape
More in-demand market research reports by the publisher can be found at VPG page.